Novel Agent Boosts Adjuvant Therapy for High-Risk Breast Cancer Novel Agent Boosts Adjuvant Therapy for High-Risk Breast Cancer

For postoperative breast cancer patients with a high risk of recurrence, the oral fluoropyrimidine-based drug S-1 could boost benefits of standard adjuvant treatment.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news